The trial reported an overall clinical response rate of 61.4% but did not reach statistical significance between the metformin + letrozole vs. placebo + letrozole cohort (66.7% versus 56.4%, p = 0.193).
← all excerpts
Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review.
1
0.1930
0.1930